The proposed updates were published for consultation but I don't think that's finished yet. (I seem to remember April being the expected time.)
Ah did not know that.
I don't know how long it'll take, but I'd guess June/July would be the earliest. I imagine the fastest part will be opening Libre 2 to those that don't currently have it (still around 40%, I think).
i currently self fund Dexcom as I wanted real time CGM so wont be interested in Libre 2.
As regularly mentioned, Libre 2 can be made to be a CGM with apps such as Diabox and xDrip. So don't discount it for it's lack of functionality compared to Dexcom if it is offered on prescription.
Would that be as accurate as Dexcom? Is the bubble mini purchased once or do you have to replace it every x days?
We are all different. I had a trial of Dexcom and found it less accurate than Libre 2 with xDrip.
Wake up you are dreaming again 🙂 It's guidance only which I suspect the CCG's will point out on more than one occasion.
Wake up you are dreaming again 🙂 It's guidance only which I suspect the CCG's will point out on more than one occasion.
Seeing pigs fly would be a bigger probability than getting a CGM out of my CCG
but it will certainly be interesting to see how CCGs in different parts of the country react to the new recommendations.
Not sure the cost effectiveness assessments have been published (I haven't seen them, anyway), but (as expected) the more widespread prescribing of Libre has produced positive data on incidents of DKA and hypos needing hospital attention, and HbA1c (all reduced, on average with use of Libre). I presume it's easy to price treatments of DKA and hypos, and maybe there's some model for the benefits of HbA1c reduction. Also I presume there's data on average reductions in cost for test strips.
Yeah. I kept having problems with the libre and using 3rd parts apps make me a llittle bit uneasy about breaking rules so ill be interested at least at sompoint trying it and may be abble to fix if it its goes wrong. Also be interested if they lasted as there were supposed. I know I might not be able to try it.
Yes, so it's quite easy to believe Libre is a net saving: reduce test strip usage a bit and an ambulance/paramedic bike call out once in a while. And (especially for DKA) expensive hospital visits (though I presume they're much rarer).
That is interesting that they are taking into account health economics when doing the studies. I think it goes further than DKA/ambulance call outs though... the long term has to be taken into account too... blindness, amputations etc. If all those can be avoided in addition to the ambulances/hospital visits etc. then it has to be win-win.
Those are surely trickier to cost, but yes, I'd have thought reductions (on average) in HbA1c ought to be worth something. Similarly, many of us who use them find them to make life easier (to the extent that we were willing to pay for them) which also ought to be valued (in terms of reducing diabetic stress).
However I offen found I needed to double check with a finger pick when I had a libre thef hadnt failed yet but because it would be hit and miss sometimes really acurte other times far out that's while they weree working. The things inserts me about dexcom is the dropping fast alerms
